Bio-Rad Laboratories Class A

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,450
Employees7,450
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,450
Employees7,450

BIO Key Statistics

Market cap
10.18B
Market cap10.18B
Price-Earnings ratio
45.42
Price-Earnings ratio45.42
Dividend yield
—
Dividend yield—
Average volume
221.67K
Average volume221.67K
High today
—
High today—
Low today
—
Low today—
Open price
$377.42
Open price$377.42
Volume
0.00
Volume0.00
52 Week high
$396.23
52 Week high$396.23
52 Week low
$236.73
52 Week low$236.73

Stock Snapshot

As of today, Bio-Rad Laboratories Class A(BIO) shares are valued at $379.29. The company's market cap stands at 10.18B, with a P/E ratio of 45.42.

On 2026-11-05, Bio-Rad Laboratories Class A(BIO) stock opened at $377.42, reached a high of —, and a low of —.

Bio-Rad Laboratories Class A(BIO) shares are trading with a volume of 0, against a daily average of 221.67K.

In the last year, Bio-Rad Laboratories Class A(BIO) shares hit a 52-week high of $396.23 and a 52-week low of $236.73.

In the last year, Bio-Rad Laboratories Class A(BIO) shares hit a 52-week high of $396.23 and a 52-week low of $236.73.

BIO News

Simply Wall St 32m
Bio Rad Laboratories Climbed While Sales Fell - Simply Wall St

...

Bio Rad Laboratories Climbed While Sales Fell - Simply Wall St
Simply Wall St 3d
Bio Rad Laboratories Draws Focus As UBS Event Tests Whether It Is Fully Valued

Bio-Rad Laboratories (BIO) is back on investors’ radar as CFO Roop K. Lakkaraju heads into a fireside chat at the UBS Global Healthcare Conference, alongside fr...

Bio Rad Laboratories Draws Focus As UBS Event Tests Whether It Is Fully Valued
Simply Wall St 5d
Bio Rad Laboratories Stock Could Be 26% Overvalued Despite Microarray Market Growth

has climbed to about US$372 a share after a mixed stretch of returns, and the key issue now is whether that level makes sense when you line it up against the ca...

People also own

Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.